Medtronic MiniMed Paradigm Insulin pump, model number MMT-522
Published April 1, 2020 · Recall initiated: June 27, 2019
Summary
FDA records medical device Class II recall Z-1587-2020, published April 1, 2020 and initiated June 27, 2019. Recalling firm: Medtronic MiniMed; Status: Ongoing; Reported quantity: 88,243; Lot: All software versions. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Medtronic MiniMed
- Distributor
- US nationwide distribution including Puerto Rico.
- Lot
- All software versions
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGlycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY,April 8, 2020
- FDAMedtronic MiniMed Paradigm Insulin pump, model number MMT-723April 1, 2020
- FDAMedtronic MiniMed Paradigm Insulin pump, model number MMT-523KApril 1, 2020
- FDAMedtronic MiniMed Paradigm Insulin pump, model numbers MMT 515 and MMT-715April 1, 2020
- FDAMiniMed Insulin Pump, model # MMT-508April 1, 2020
- FDALN 3R70-01; software version 2.6.2 and earlier. The software is used with the Alinity i (LN 03R65-01)April 1, 2020
Questions about this recall
Was Medtronic MiniMed Paradigm Insulin pump, model number MMT-522 recalled?
Yes. FDA published recall Z-1587-2020 on April 1, 2020. Reported hazard: The action is being initiated due to potential cybersecurity vulnerabilities related to a series of insulin pumps that are designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
What should I do if I have this product?
Voluntary: Firm initiated · Letter